-:2

Panpan Zhang1, Shengmian Li2, Ru Jia3

  • 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute, Beijing, 100142, China.

EClinicalMedicine
|November 10, 2025
PubMed
概括

在先进的肺外神经内分泌癌 (EP-NEC) 患者中,纳布-帕克利塔塞尔加贝瓦齐祖马布显示出高响应率和令人鼓舞的存活率. 这种组合为那些已经耗尽标准疗法的人提供了潜在的新治疗选择.